跳转至内容
Merck
CN

Synthesis of spiropiperidine lactam acetyl-CoA carboxylase inhibitors.

The Journal of organic chemistry (2012-11-07)
Kim Huard, Scott W Bagley, Elnaz Menhaji-Klotz, Cathy Préville, James A Southers, Aaron C Smith, David J Edmonds, John C Lucas, Matthew F Dunn, Nigel M Allanson, Emma L Blaney, Carmen N Garcia-Irizarry, Jeffrey T Kohrt, David A Griffith, Robert L Dow
摘要

The synthesis of 4',6'-dihydrospiro[piperidine-4,5'-pyrazolo[3,4-c]pyridin]-7'(2'H)-one-based acetyl-CoA carboxylase inhibitors is reported. The hitherto unknown N-2 tert-butyl pyrazolospirolactam core was synthesized from ethyl 3-amino-1H-pyrazole-4-carboxylate in a streamlined 10-step synthesis requiring only one chromatography procedure. The described synthetic strategy provides pyrazolo-fused spirolactams from halogenated benzylic arenes and cyclic carboxylates. Key steps include a regioselective pyrazole alkylation providing the N-2 tert-butyl pyrazole and a Curtius rearrangement under both conventional and flow conditions to install the hindered amine via a stable and isolable isocyanate. Finally, a Parham-type cyclization was used to furnish the desired spirolactam. An analogous route provided efficient access to the related N-1 isopropyl lactam series. Elaboration of the lactam cores via amidation enabled synthesis of novel ACC inhibitors and the identification of potent analogues.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
Acetyl-CoA carboxylase 2 human, recombinant, expressed in Sf9 cells
Sigma-Aldrich
乙酰辅酶 A 羧化酶 1 人, recombinant, expressed in Sf9 cells